NEWS CENTER

Renowned financial writer Wu Xiaobo visited Keyuan Pharmaceutical, praising the company’s achievements in digital and intelligent transformation.

Publish Time:

2026-05-17

On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating intelligent manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with its core management team, and expressed strong recognition of its practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.

On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating intelligent manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with the company’s core management team, and expressed high praise for its practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.

Wu Xiaobo and his delegation successively visited the API production base and the injectable‑drug facility of Keyuan Pharmaceutical. AI + At the Computing Power Intelligent Factory Base, the delegation conducted an on-site visit to a benchmark scenario of enterprise digitalization and intelligent transformation. At the API production base, the team gained an in-depth understanding of the company’s end-to-end smart management system, built on industrial internet and big data technologies. This system enables real-time collection of production data, intelligent monitoring of equipment status, and precise early warning of quality risks, thereby driving simultaneous improvements in both production efficiency and quality control. Wu Xiaobo commented that Keyuan Pharmaceutical will… AI The exploration of integrating technology into every stage of production management was commended, with the view that it provides a practical model for the digital transformation of traditional pharmaceutical enterprises.

At the site of the injectable‑drug smart manufacturing project, Chairman Li Hongfu provided a detailed overview of the core strengths of this major provincial-level initiative for transforming old and new growth drivers. The smart factory has a total investment exceeding… 5 hundred million yuan, with a total floor area of approximately 46000 square meters, deeply integrating digital twins, AI Visual inspection, 5G Industrial interconnection, AGV Cutting-edge technologies such as smart logistics have been implemented, and lyophilized powder for injection has been established… BFS Two state-of-the-art, fully automated intelligent production lines have established an end-to-end digital and intelligent control system spanning R&D, manufacturing, quality inspection, and warehousing, setting a new benchmark for smart manufacturing of high‑end injectable products.

In recent years, the company has continued to ramp up its investments. AI Technology roadmap, rolling out across all employees. AI Application training, driving forward AI It has been implemented in core areas such as drug development, intelligent manufacturing, quality control, and supply chain management; three large-scale digital and intelligent production bases have been established, with the oral solid dosage form base already having obtained… CMMM 三级 certification certificate, recognized as an “Outstanding National Case of Digital and Intelligent Transformation in the Pharmaceutical and Greater Health Sector,” and the injectable‑drug manufacturing base was selected as… 2026 “Jinan City’s Basic-Level Smart Factory of the Year.”

Wu Xiaobo highly commended Keyuan Pharmaceutical for its achievements in intelligent manufacturing and digitalization. AI innovative practices in the field. He stated that the pharmaceutical industry is entering a critical phase of digital and intelligent transformation. Keyuan Pharmaceutical is closely aligned with the industry’s evolving trends, leveraging technological innovation to address longstanding challenges in traditional drug manufacturing. By bridging the gap from active pharmaceutical ingredients to finished dosage forms and from conventional production to smart, digital manufacturing, the company has not only demonstrated its robust capabilities but also provided valuable, replicable insights for the transformation and upgrading of China’s pharmaceutical sector. The company will take this exchange as an opportunity to further deepen… AI Integration of technology with the entire pharmaceutical industry chain, with a sustained focus on intelligent manufacturing and digitalization. AI — Adhering to the three major strategic directions of green and low-carbon development, we remain committed to innovation-driven growth and digital‑intelligent empowerment, striving to become a leading benchmark enterprise in the industry for digital and intelligent transformation.

Keyuan Group Conducts Company-Wide Training on Integrity and Compliance, Strengthening the Pharmaceutical Company’s Integrity Defense Line

Dual Exhibitions on One Stage, Full-Chain Collaboration | Keyuan Pharmaceutical, together with its subsidiary Linuo Pharmaceutical, jointly showcased at the Shanghai International Pharmaceutical Dual Exhibitions!

Keyuan Group Conducts Company-Wide Training on Integrity and Compliance, Strengthening the Pharmaceutical Company’s Integrity Defense Line